Dr Timothy Chevassut
Qualifications
BMBCh MA Oxford University 1993, MPH Harvard University 1998, PhD Edinburgh University 2006, FRCP Royal College of Physicians 1996, FRCPath Royal College of Pathologists 2006
GMC number: 4032117
Practising since: 1996
Specialties
Haematology, Clinical Oncology
Consultation times
- By appointment
- Overview
Or call us on
About
Dr Chevassut has been a consultant haematologist in Brighton since 2007 and also works as a clinical academic doing research across many areas of blood disorders, including cancer. He studied medicine at Oxford University and worked clinically at the John Radcliffe Hospital, Bristol Royal Infirmary, and Royal Devon and Exeter Hospital, gaining Membership in the Royal College of Physicians, before moving to Boston, USA, where he undertook a Master's degree and Research Fellowship at Harvard University. He went on to complete a PhD in molecular and stem cell biology at Edinburgh University and subsequently completed specialist clinical training on the East of Scotland haematology programme, where he gained Membership in the Royal College of Pathologists.
Dr Chevassut is a haematology consultant at the Royal Sussex County Hospital and was appointed to Professor of Haematology at Brighton and Sussex Medical School in 2021. He has conducted research into leukaemia, lymphoma, and myeloma, amongst other blood disorders, and has been principal investigator on a number of clinical trials. He is a Fellow of the Royal College of Physicians and Royal College of Pathologists and an Associate Editor for Clinical Medicine. He has extensive experience in supervising the training of junior doctors and enjoys close working relations with clinical and laboratory colleagues as well as overseeing the haematology pathology services at the Nuffield Hospital.
Special interests
- Clinical haematology
- Chronic myeloid leukaemia
- Essential thrombocythemia
- Myelofibrosis
- Myelodysplasia
- Myeloma
- Lymphoma
- Bleeding disorders
- Thrombophilias
- Iron infusions
- Raised ferritin
- Chronic lymphocytic leukaemia
- Imaging scans
- Targeted therapies
Personal interests
Dr Chevassut is married and enjoys spending time with his family in Sussex, walking the Downs, running and cycling, and the local theatres and cinemas in Brighton and Lewes.
Languages spoken
English
Treatments and tests offered by Dr Timothy Chevassut at Nuffield Health
- Blood test
- Chemotherapy
- Haemato-oncology
- Haematology profiles
- Ultrasound
Locations Dr Timothy Chevassut works with
Related experience
Research
Dr Chevassut conducts a successful translational research programme in AML and MDS that aims to better understand the biology of these conditions through basic science with a view to improving treatments for patients through clinical trials. The basic laboratory research is conducted at the BSMS Medical Research Building at the University of Sussex and focuses on the molecular mechanisms of leukaemogenesis. Dr Chevassut conducts a successful translational research programme in AML and MDS that aims to better understand the biology of these conditions through basic science with a view to improving treatments for patients through clinical trials.
Dr Chevassut has also established the Brighton Bone Marrow Tissue Bank containing samples from patients with AML, MDS and other forms of blood cancer that serves as an invaluable research resource. In collaboration with other investigators at the University of Sussex, notably the Genome Centre and the Drug Discovery Centre, the Tissue Bank will facilitate the development of diagnostic assays for disease profiling and drug testing.
Finally, Dr Chevassut has established a highly regarded early phase clinical trial unit at CIRU (Clinical Investigation Research Unit), based at the Royal Sussex County Hospital. He is the principal investigator for four studies in MDS and AML, including two for which he is the UK Chief Investigator, which aims to improve treatment options for patients using a variety of targeted therapies such as monoclonal antibodies, antisense molecules and DNA hypomethylation.
Memberships
- British Society of Haematology
- NCRI Myelodysplasia Subgroup
- Royal College of Pathologists (2010)
- Royal College of Physicians (2011)
Declaration
Dr Timothy Chevassut does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Timothy Chevassut does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Timothy Chevassut holds the following paid advisory role(s) either at this hospital or on behalf of Nuffield Health:
Dr Timothy Chevassut is paid £5,353 for advisory services relating to haematology at Nuffield Health Brighton Hospital.